The Use of Recombinant Activated FVII (rFVIIa, Novoseven®) in the Treatment of Patients with Haemophilia and Inhibitors

Diniz, MJGalvão, MTavares, AVieira, AFalcão, MTCatarino, CCruz, C2011-11-302011-11-302000IN: XXIV International Congress of the World Federation of Hemophilia, 2000, 16 a 21 Julho. Montreal, Canadá.http://hdl.handle.net/10400.17/520engFactor VIIaHemofilia AHemofilia BEstudos RetrospectivosThe Use of Recombinant Activated FVII (rFVIIa, Novoseven®) in the Treatment of Patients with Haemophilia and Inhibitorsother